Aslan Pharmaceuticals Ltd ADR (ASLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASLN | AMGN | BMY | VRTX | GILD |
| Company | Aslan Pharmaceuticals Ltd ADR | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.6300 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 0.7000 | 289.84 | 58.22 | 455.43 | 89.34 |
| Low | 0.6000 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 0.6000 | 288.24 | 57.99 | 446.80 | 89.23 |
| Change | -0.0999 | +0.37 | +0.11 | -4.43 | +0.60 |
| % Change | -14.27% | +0.13% | +0.19% | -0.98% | +0.68% |
| Volume | 806,300 | 768,694 | 2,087,970 | 397,516 | 1,039,134 |
| 20-Day Average Volume | 289,117 | 2,781,059 | 12,124,233 | 1,288,199 | 7,375,203 |
| Previous Close | 0.6999 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.0725 | 307.35 | 55.91 | 479.18 | 90.86 |
| 20-Day Raw Stochastic | 5.23% | 24.65% | 66.24% | 5.58% | 24.57% |
| 20-Day Relative Strength | 25.90% | 35.42% | 60.08% | 40.59% | 52.42% |
| Weighted Alpha | -93.79 | +1.27 | +25.22 | +17.66 | +25.04 |
| Today's Opinion | 100% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 100% Sell | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -75.71% since 07/11/24 | -2.49% since 11/14/24 | -0.94% since 11/14/24 | -7.16% since 11/14/24 | -3.13% since 11/14/24 |
| Low | 0.4750 on 07/17/24 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 2.7314 on 07/12/24 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | -75.97% since 06/18/24 | -8.90% since 10/21/24 | +11.19% since 10/21/24 | -6.02% since 10/21/24 | +3.41% since 10/21/24 |
| Low | 0.4750 on 07/17/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 2.8640 on 06/21/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -86.11% since 04/18/24 | -12.33% since 08/21/24 | +19.63% since 08/21/24 | -7.57% since 08/21/24 | +18.77% since 08/21/24 |
| Low | 0.4750 on 07/17/24 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 4.8968 on 04/22/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -85.84% since 01/18/24 | -8.35% since 05/21/24 | +37.09% since 05/21/24 | +1.65% since 05/21/24 | +32.61% since 05/21/24 |
| Low | 0.4750 on 07/17/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 16.7200 on 03/12/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,226 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 2,044 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 12,000,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -44,220,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -9,920,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 1.40 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -10.32 on 05/09/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 08/09/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |